ELENA KONAKOVA: Open Payments
NPI 1124449434 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 49 payments from 16 companies in 2025. Trend: 2023 $1,413 · 2024 $1,057 · 2025 $1,398
Food & beverage: $1,398
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $201 |
| Lilly USA, LLC | 5 | $201 |
| Amgen Inc. | 5 | $190 |
| PFIZER INC. | 4 | $168 |
| ABBVIE INC. | 3 | $167 |
| Janssen Pharmaceuticals, Inc | 4 | $150 |
| Exact Sciences Corporation | 3 | $66 |
| Novo Nordisk Inc | 3 | $61 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
Products named: PREVNAR 20, KISUNLA, SPRAVATO, REPATHA, AIRSUPRA, OTEZLA, FARXIGA, ZENPEP.
Industry payments across PA — which companies pay providers there.
